OUR THERAPEUTIC AREAS
Our medicines fit into 5 therapeutic areas – Neuropsychiatry, Venous diseases, Cardiovascular, Diabetes and Oncology.
At Servier our primary focus is and always will be researching, developing, and fine-tuning innovative medicines.
For nearly 50 years our medicines have been the fruits of our R&D labor. Over the past decade, we have also been forging agreements with other companies to access novel treatments.
NEUROPSYCHIATRY
Depression and Anxiety are very common mental disorders, associated with considerable suffering for sufferers and those around them, and generating considerable handicaps in daily life, social life and professional life.
Depression goes hand in hand not only with a significant decline in social relationships, but also with a feeling of loss of support from those around them – and above all with a strong sense of loneliness and exclusion.
Servier is concentrating its efforts on the drug offer capable of acting on several depressive and anxiety symptoms at once, to help patients returning to an active life.
In the field of neuroscience, Servier focuses its research on neurodegenerative diseases. Servier targets proteinopathies, characterized by abnormal accumulation of certain proteins, such as Parkinson’s disease or rare diseases like amyotrophic lateral sclerosis.
VEINOUS DISEASES
Venous diseases are caused by damage to the venous system, whose function is to return blood to the heart.
Overall, 8 out of 10 1 people suffer from symptoms such as heavy and/or painful legs, night cramps and even venous oedema or ulcers.
Hemorrhoidal disease can also be traced back to an alteration in the venous system.
Servier is a pioneer in the treatment of these pathologies, with its naturally-derived active ingredient based on flavonoid-rich immature oranges.
1 Rabe E et al., Epidemiology of chronic venous disorders in geographically diverse populations: results from the Vein Consult Program, International Angiology (2012) 31(2):105-15.
CARDIOVASCULAR
DISEASES
Cardiovascular diseases are a group of diseases affecting the heart and blood vessels, have consistently ranked as the second leading cause of death among the population in Taiwan and are the leading cause of mortality in the world. Committed for more than 60 years to the treatment of these pathologies, Servier has acquired renowned expertise in these areas.
Heart failure is a serious health problem, representing the main cause of hospitalization and readmission in people over 65. For adult Taiwanese, the lifetime risk of heart failure is 1 in 5 for women and 1 in 4 for men1.
We have been serving doctors and patients with heart failure for over 25 years, offering different therapeutic solutions in this area.
1 Chiang CE, Hung CL, Wu YW, Lin TH, Ueng KC, Sung SH, Wu CK, Chao TH, Lin HJ, Lin YH et al (2023) 2023 Consensus of Taiwan Society of Cardiology on the Pharmacological Treatment of Chronic Heart Failure. Acta Cardiol Sin 39(3):361–390
DIABETES
Diabetes is a chronic illness caused by elevated levels of blood glucose (or ‘blood sugar’), which leads over time to serious damage to the heart, blood vessels, eyes, kidneys and nerves. The most common is type 2 diabetes, usually in adults, which occurs when either the body becomes resistant to the effects of insulin or the pancreas doesn’t make enough insulin (insulin is a hormone that regulates glucose levels in the blood). In the past 3 decades, the number of patients diagnosed with type 2 diabetes has risen dramatically in countries of all income levels.
ONCOLOGY
Cancer has consistently ranked as the first leading cause of death among the population in Taiwan and the second leading cause of death worldwide, and numbers are on the rise. To respond to the growing need and to give people affected by cancer hope through innovative therapeutic solutions, Servier has made oncology one of its foremost priorities.
Servier is striving to become a renowned and innovative player in the treatment of difficult-to-treat cancers. In this context, we are focusing on gastrointestinal cancers (stomach, colon and pancreatic cancer), hematology (including pediatric hematology) as well as brain tumors.
